Advertisement

COVID-19 Federal Responses: Thursday, July 28, 2022

COVID-19 Federal Responses: Thursday, July 28, 2022

White House and Federal Agencies

  • The White House announced the launch of a new effort to develop the next generation of COVID-19 vaccines, including Omicron-specific boosters, focused on innovation of next-generation manufacturing and vaccine delivery.

Economy, Vaccines, Testing and Treatment

  • A CDC analysis found that immunocompromised patients accounted for 12.2% of all COVID-19-related hospitalizations.
  • The two doses of the Pfizer/BioNTech COVID-19 vaccine are 82.7% effective against Omicron hospitalizations in kids aged 5-11.
  • An industry survey has found that more than 40% of the U.S. public health workforce intend to leave their jobs within five years. The survey highlights the COVID-19 pandemic as the main issue driving the exit from the healthcare industry.
  • This month, hospitals in close to 40 states reported critical staffing shortages, marking a long-term problem as hospitals realize federal funding for the pandemic is beginning to run out.
  • The BA.5 Omicron Subvariant is accountable for 80% of new COVID-19 infections in the U.S. and is also causing reinfections across the country.
  • A Kaiser Family Foundation survey found that 43% of parents of children under 5 years old do not intend to vaccinate their child against COVID-19.
  • Experts are hopeful about the development of nasal spray COVID-19 vaccines to offer Americans more options to provide reliable protection against the pandemic.
  • A new study suggests COVID-19 patients who smoke or vape are 39% more likely to be put on a ventilator and 45% more likely to pass away from the disease.
  • Women who contract COVID-19 in the third trimester of pregnancy have been found to be 2.76 times more likely to have a preterm birth.
  • Patients with high blood pressure that contract Omicron are 2.6 times more likely to be hospitalized.

Advertisement